Details for 2020847777

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATIONSPRODUKT AUS BCL-2/BCL-XL-INHIBITOR UND CHEMOTHERAPEUTIKUM UND VERWENDUNG DAVON ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON ERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020847777

EP Publication Number

3843751

E-Number

1669267

Language

PCT Number

CN20105810

Publication Date

07.07.2021 A

27.03.2024 B1

Registration Date

27.03.2024

AT Publication Date

15.04.2024

Application Date

30.07.2020

Registration Number

Priorities

31.07.2019

PCT/CN2019/098625

03.07.2020

202010631089

IPC

A61K 31/496 20060101AFI20230922BHEP

Maximum Duration of Protection

30.07.2040

Owner

Ascentage Pharma (Suzhou) Co., Ltd.Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215000CN

Ascentage Pharma Group Corp Limited9/F, Wah Yuen Building 149 Queen's Road Central Hong KongHK

Representative

No representatives present

Inventor

YANG, DajunUnit 701, Building B7 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

ZHAI, YifanUnit 701, Building B7 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

FANG, Douglas DongUnit 701, Building B7 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

TANG, QiuqiongUnit 701, Building B7 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN